Your browser doesn't support javascript.
loading
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.
Lindemann, K; Christensen, R D; Vergote, I; Stuart, G; Izquierdo, M A; Kærn, J; Havsteen, H; Eisenhauer, E; Ridderheim, M; Lopez, A B; Hirte, H; Aavall-Lundquvist, E; Vrdoljak, E; Green, J; Kristensen, G B.
Afiliação
  • Lindemann K; Department of Gynecological Cancer, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Christensen RD; Department of Medical Statistics, University of Southern Denmark, Odense, Denmark.
  • Vergote I; Department of Obstetrics and Gynecology, University Hospital Leuven, Leuven, Belgium.
  • Stuart G; Department of Gynecologic Oncology, University of British Columbia, Vancouver, Canada.
  • Izquierdo MA; Institute of Oncology, Catalán Hospital, Catalania, Spain.
  • Kærn J; Department of Gynecological Cancer, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
  • Havsteen H; Department of Oncology, Herlev University Hospital, Herlev, Denmark.
  • Eisenhauer E; Department of Oncology, Queen's University, Kingston, Ontario, Canada.
  • Ridderheim M; Department of Gynecologic Oncology, Lund University Hospital, Lund, Sweden.
  • Lopez AB; Department of Gynecologic Oncology, Queen Elizabeth Hospital, Gateshead, UK.
  • Hirte H; Department of Oncology, Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, Ontario, Canada.
  • Aavall-Lundquvist E; Department of Oncology, Karolinska University Hospital, Stockholm, Sweden.
  • Vrdoljak E; Department of Oncology, University Hospital, Split, Croatia.
  • Green J; Department of Oncology, Clatterbridge Hospital, Wirral, UK.
  • Kristensen GB; Department of Gynecological Cancer, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; Department of Gynecological Cancer, Institute for Medical Informatics, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Electronic address: gunnar.b.kristensen@gmail.com.
Ann Oncol ; 23(10): 2613-2619, 2012 Oct.
Article em En | MEDLINE | ID: mdl-22539562
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Noruega
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2012 Tipo de documento: Article País de afiliação: Noruega